Literature DB >> 19886658

Different modes of inhibitor binding to prolyl hydroxylase by combined use of X-ray crystallography and NMR spectroscopy of paramagnetic complexes.

Leszek Poppe1, Christopher M Tegley, Vivian Li, Jeffrey Lewis, James Zondlo, Evelyn Yang, Robert J M Kurzeja, Rashid Syed.   

Abstract

In aqueous solution, azaquinolone inhibitors bind to prolyl 4-hydroxylase in two different orientations, as first detected by (19)F spectroscopy. This contrasts with the crystallographic structure where only one orientation has been determined. Dissection of the metal binding properties of the enzyme allowed structures of both complexes to be obtained in solution from (19)F and (13)C dipolar shifts in a labeled ligand.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19886658     DOI: 10.1021/ja907933p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  6 in total

1.  Modulating carnitine levels by targeting its biosynthesis pathway - selective inhibition of γ-butyrobetaine hydroxylase.

Authors:  Anna M Rydzik; Rasheduzzaman Chowdhury; Grazyna T Kochan; Sophie T Williams; Michael A McDonough; Akane Kawamura; Christopher J Schofield
Journal:  Chem Sci       Date:  2014-05-01       Impact factor: 9.825

2.  Protein Flexibility of the α-Ketoglutarate-Dependent Oxygenase Factor-Inhibiting HIF-1: Implications for Substrate Binding, Catalysis, and Regulation.

Authors:  Cristina B Martin; Vanessa D Chaplin; Stephen J Eyles; Michael J Knapp
Journal:  Biochemistry       Date:  2019-09-20       Impact factor: 3.162

3.  Structure of human RNA N⁶-methyladenine demethylase ALKBH5 provides insights into its mechanisms of nucleic acid recognition and demethylation.

Authors:  WeiShen Aik; John S Scotti; Hwanho Choi; Lingzhi Gong; Marina Demetriades; Christopher J Schofield; Michael A McDonough
Journal:  Nucleic Acids Res       Date:  2014-01-30       Impact factor: 16.971

4.  Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases.

Authors:  Shoichiro Horita; John S Scotti; Cyrille Thinnes; Yousef S Mottaghi-Taromsari; Armin Thalhammer; Wei Ge; WeiShen Aik; Christoph Loenarz; Christopher J Schofield; Michael A McDonough
Journal:  Structure       Date:  2015-02-26       Impact factor: 5.006

Review 5.  Targeting histone lysine demethylases - progress, challenges, and the future.

Authors:  Cyrille C Thinnes; Katherine S England; Akane Kawamura; Rasheduzzaman Chowdhury; Christopher J Schofield; Richard J Hopkinson
Journal:  Biochim Biophys Acta       Date:  2014-05-21

6.  Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.

Authors:  Tzu-Lan Yeh; Thomas M Leissing; Martine I Abboud; Cyrille C Thinnes; Onur Atasoylu; James P Holt-Martyn; Dong Zhang; Anthony Tumber; Kerstin Lippl; Christopher T Lohans; Ivanhoe K H Leung; Helen Morcrette; Ian J Clifton; Timothy D W Claridge; Akane Kawamura; Emily Flashman; Xin Lu; Peter J Ratcliffe; Rasheduzzaman Chowdhury; Christopher W Pugh; Christopher J Schofield
Journal:  Chem Sci       Date:  2017-09-11       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.